TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ARGX

argenx NV

Healthcare · Biotechnology

851.30$ -0.7% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Balance Sheet

argenx NV (ARGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 8,683 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARGX
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12 32 23 35 59 50 111 445 662 1,610 2,279 2,850 3,134 4,542 6,203 8,683
12 32 22 34 57 48 107 440 655 1,543 2,057 2,543 2,774 4,124 4,883 6,899
11 31 20 31 39 39 95 229 321 372 1,217 1,335 801 2,049 1,500 3,491
11 31 22 32 68 46 102 432 646 1,501 1,996 2,337 2,193 3,180 3,379 4,440
1.4 0.6 0.1 1.5 1.6 0.7 1.1 3.1 3.6 23 7.4 38 277 499 909 1,657
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 -1,023 25 109 228 311 407 474
0.1 0.2 0.3 0.8 0.7 0.8 8.2 9.5 16 16
0.0 0.0 0.0 0.0 0.0 0.0 6.3
0.0 0.0 0.0 0.0 0.0 0.0 0.1 45 167 172 175 125 181 272
2.0 4.0 6.3 4.6 8.4 9.4 45 31 46 430 605 316 321 445 704 1,360
2.0 4.0 6.3 4.6 10 9.4 34 29 46 180 328 301 302 423 670 1,320
1.7 1.7 0.0 0.0 0.0 0.0 0.0 2.2 3.5 3.5 3.4 4.6 6.5 11
1.7 0.9 2.5 2.9 4.1 2.9 4.6 5.3 6.9 11 206 209 189 246 342 1,267
0.0 0.0 0.0 0.0 0.0 0.0
10 28 17 30 61 41 67 414 616 1,180 1,674 2,534 2,814 4,098 5,498 7,323
-8.4 -13 -26 -35 -44 -56 -76 -121 -194 -383 -992 -1,400 -2,110 -2,405 -1,572 -280
16 16 16 16 16 16 19 25 36 39 45 51 54 57 65 66

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?